Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rettenbacher

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Schizophrenia Research|February 8, 2022
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosisFarivar Fathian, Rolf Gjestad, Rune A Kroken, et al.
The Lancet. Psychiatry|October 18, 2020
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trialErik Johnsen, Rune A Kroken, Else-Marie Løberg, et al.
Psychiatry Research|June 20, 2026
Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapineRune Andreas Kroken, Erik Johnsen, Renata Alisauskiene, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Schizophrenia Research|February 8, 2022
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosisFarivar Fathian, Rolf Gjestad, Rune A Kroken, et al.
The Lancet. Psychiatry|October 18, 2020
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trialErik Johnsen, Rune A Kroken, Else-Marie Løberg, et al.
Psychiatry Research|June 20, 2026
Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapineRune Andreas Kroken, Erik Johnsen, Renata Alisauskiene, et al.
Pageof 3